Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Intraarticular Steroid Injection for Enhancing Pain Relief in Adhesive Capsulitis
Recruiting now · Not applicable
Conditions studied: Analgesia
In brief
Improving pain in the patients with adhesive capsulitis by comparing the effect of combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection.
Key facts
- Study ID
- NCT07235982
- Run by
- Zagazig University
- People needed
- 50
- Starts
- 2025-10-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2025-11-19
Who can join
Age: 41 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients acceptance
- Age: 41-65 years old
- Sex: both sex (males or females).
- Physical status: American Society of Anesthesiologist (ASA) І, II.
- Patients attend orthopedic or pain clinic with complaint of shoulder pain and stiffness. These patients received conservative management of pain with no relief of symptoms for at least 2 weeks.
You may not qualify if…
- Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder.
- Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
- Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).
- Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.
- History of neuropathy in the involved limb or previous revision surgery.
Where it is running
- Faculity of Medicine, Zagazig University — Zagazig, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.